Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T12:01:27.439Z.
Calculation as of: 2026-10-06T12:01:27.439Z.
Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 370e13d786cc28e63fbc6719e554b7ac483294971c86eef7c80c09e39811c756
EARNINGS YIELD
N/A
Market Cap
$734.10M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$767.46M
Earnings Yield
N/A
TTM Avg
0.35%
3Y Avg
0.35%
5Y Avg
0.35%
Market Cap
$774.32M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$719.64M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$786.48M
Earnings Yield
N/A
TTM Avg
0.13%
3Y Avg
0.36%
5Y Avg
0.36%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Candel Therapeutics, Inc. (CADL) | $749.55M | N/A | N/A | N/A | N/A |
| Anteris Technologies Global Corp. (AVR)vs › | $734.10M | N/A | N/A | N/A | N/A |
| Avalo Therapeutics, Inc. (AVTX)vs › | $767.46M | N/A | 0.35% | 0.35% | 0.35% |
| Attovia Therapeutics, Inc. (ATTO)vs › | $774.32M | N/A | N/A | N/A | N/A |
| Design Therapeutics, Inc. (DSGN)vs › | $775.72M | N/A | N/A | N/A | N/A |
| Geron Corporation (GERN)vs › | $776.24M | N/A | 0.17% | 0.17% | 0.17% |
| Achieve Life Sciences, Inc. (ACHV)vs › | $719.64M | N/A | N/A | N/A | N/A |
| AdaptHealth Corp. (AHCO)vs › | $780.95M | N/A | 5.97% | 4.36% | 4.36% |
| Cytek Biosciences, Inc. (CTKB)vs › | $786.48M | N/A | 0.13% | 0.36% | 0.36% |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $709.33M | 5.67% | 4.56% | 4.80% | 6.03% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
